Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Change in Acquisitions & Divestments (2021 - 2025)

Historic Change in Acquisitions & Divestments for Krystal Biotech (KRYS) over the last 5 years, with Q4 2025 value amounting to $85.8 million.

  • Krystal Biotech's Change in Acquisitions & Divestments rose 4177.04% to $85.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $375.6 million, marking a year-over-year increase of 2582.58%. This contributed to the annual value of $375.6 million for FY2025, which is 2582.58% up from last year.
  • Latest data reveals that Krystal Biotech reported Change in Acquisitions & Divestments of $85.8 million as of Q4 2025, which was up 4177.04% from $95.8 million recorded in Q3 2025.
  • Krystal Biotech's 5-year Change in Acquisitions & Divestments high stood at $161.2 million for Q2 2023, and its period low was $1.2 million during Q2 2021.
  • Its 5-year average for Change in Acquisitions & Divestments is $73.4 million, with a median of $76.9 million in 2023.
  • As far as peak fluctuations go, Krystal Biotech's Change in Acquisitions & Divestments surged by 499261.96% in 2022, and later tumbled by 5883.06% in 2024.
  • Quarter analysis of 5 years shows Krystal Biotech's Change in Acquisitions & Divestments stood at $21.0 million in 2021, then soared by 395.73% to $104.1 million in 2022, then decreased by 28.33% to $74.6 million in 2023, then decreased by 18.9% to $60.5 million in 2024, then soared by 41.77% to $85.8 million in 2025.
  • Its Change in Acquisitions & Divestments was $85.8 million in Q4 2025, compared to $95.8 million in Q3 2025 and $105.3 million in Q2 2025.